GlassScriptPhysician profile
Anthony L Cucuzzella
NPI 1710948260
$672.58
in general payments reported to CMS, 2019-2025
10 companies · $106 in 2025
The $106 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $235 · 2020: $84.86 · 2021: $104 · 2022: $80.01 · 2023: $40.27 · 2024: $22.50 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $168.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $347.19 | 2019-2025 | Ztlido |
| Galderma Laboratories, L.P. | $116.94 | 2019-2025 | Dysport |
| International Rehabilitative Sciences, INC | $38.69 | 2025 | Rs-4i Plus With Intersperse |
| Pacira Therapeutics, INC. | $35.35 | 2019 | |
| Globus Medical, INC. | $33.45 | 2025 | Senza |
| Medtronic USA, INC. | $25.52 | 2019-2020 | |
| Foundation Fusion Solutions, LLC | $24.45 | 2021 | |
| Ibsa Pharma INC. | $20.47 | 2021 | |
| Redhill Biopharma INC. | $15.89 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Cucuzzella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.